In this article, we will discuss: 10 Best Brain-Computer Interface Stocks to Buy.
On May 10, Bloomberg reported that brain-computer interfaces are transitioning from experimental to early implementation, allowing users to control computers, robotic arms, and communication tools with neural signals. Researchers have developed implanted and non-invasive devices that translate brain activity into commands, helping patients with paralysis and neurological disorders to regain function. Based on the report, just a few hundred people have received implants due to limited regulatory permissions, but developments in artificial intelligence and hardware are speeding up progress and moving the industry toward an inflection point.
According to Bloomberg, investment momentum is rising in the area, with Elon Musk and Sam Altman backing it. Elon Musk’s Neuralink has implanted devices in over 20 patients and plans to scale to 20,000 per year by 2031, whereas Synchron has tested devices in approximately 10 patients. Bloomberg data showed US BCI funding touched $2.75 billion, while China’s sector surpassed 1.8 billion yuan in 2025, showing rising global investment and competition.
With that said, here are the 10 Best Brain-Computer Interface Stocks to Buy.
Methodology:
We used screeners to identify Best Brain-Computer Interface Stocks and limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and elite hedge funds. We then identified those with the highest number of hedge fund holders, which we assessed using Insider Monkey’s database of hedge funds as of Q1 2026. The stocks are ranked in ascending order of the number of hedge fund holders.
Note: This list includes both pure-play BCI developers and supporting infrastructure businesses.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Insider Monkey’s quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 599.2% since May 2014, beating its benchmark by 372 percentage points (see more details here).
10. CeriBell, Inc. (NASDAQ:CBLL)
Number of Hedge Fund Holders: 15
CeriBell, Inc. (NASDAQ:CBLL) is among the Best Brain-Computer Interface Stocks.
On June 8, CeriBell, Inc. reported a study published in Critical Care Medicine that higher AI-detected seizure burden is linked with increased odds of disability results at discharge. It analyzed 359 adult patients across three academic centers.
The company said patients with a peak seizure burden of at least 90% were 3.4 times more likely to experience death or severe disability compared to those with no seizure burden. Hence, the elevated burden directly leads to poorer functional outcomes.
The medtech firm revealed that risk develops with time. It stated that each additional hour of AI-detected seizure activity nearly doubled the odds of severe disability or death, noting an adjusted odds ratio of 1.98.
Lead author Josef Parvizi said the algorithm detects clinically relevant biomarkers with prognosis, underlining potential for earlier intervention.
CEO Jane Chao said continuous monitoring allows live assessment and more informed clinical decisions.
CeriBell, Inc. is a commercial-stage medical technology firm that works to transform the diagnosis and treatment of patients with severe neurological conditions.
9. NeuroPace, Inc. (NASDAQ:NPCE)
Number of Hedge Fund Holders: 23
On May 29, NeuroPace, Inc. (NASDAQ:NPCE) said it received U.S. Food and Drug Administration approval for ECoG Assistant, the first “AI-driven clinician-enabled feature.” It is designed to help epilepsy care using long-term intracranial EEG data.
Built on 124,450 epileptologist-labeled records, the company reported that the tool has “ECoGs of Interest.” It allows physicians to review trends and timing patterns across months through integrated reports and charts, improving efficiency in data review and treatment decisions.
Chief Medical Officer Martha Morrell said the feature “represents an important advancement,” with faster access to insights for more informed care.
CEO Joel Becker said the approval shows how the firm’s data advantage is moving toward “practical tools for clinicians.”
NeuroPace, Inc. debuted the technology at the ASSFN Annual Meeting on May 30. It has submitted its next-generation patient data platform for FDA review, targeting approval in the second quarter of 2026.
NeuroPace, Inc. creates, produces, and markets implantable devices to treat epilepsy and neurological illnesses. It offers implantable components such as the RNS neurostimulator and depth and cortical strip leads.
8. Butterfly Network, Inc. (NYSE:BFLY)
Number of Hedge Fund Holders: 26
Butterfly Network, Inc. (NYSE:BFLY) is among the Best Brain-Computer Interface Stocks.
On June 18, Butterfly Network, Inc. commented on Midjourney’s launch of a full-body imaging system, outlining its role in the scanner’s underlying hardware and future scaling plans. The company said the current prototype integrates 40 Ultrasound-on-Chip imaging modules per system under an existing co-development agreement. The future versions are expected to use significantly more modules as the platform grows.
CEO Joseph DeVivo called the system “an extraordinary whole-body scanner,” stating it works without radiation or magnetic risk and uses “about half a million sensors” and more than two petaflops of processing power. He added that the device is designed for frequent use, allowing continuous monitoring of physiological changes.
DeVivo said Butterfly Network, Inc. supports Midjourney’s effort to expand access to imaging data, calling the roadmap introduced by founder David Holz a potential commercial opportunity. The company also noted its prior agreement outlines up to $74 million in expected payments over five years.
Butterfly Network, Inc. develops a medical imaging device that lowers the cost of real-time, three-dimensional imaging and treatment. It develops and markets the iQ Device, a whole-body portable ultrasound scanner, as well as related hosted, web-based applications, application programming interfaces, and platform services to physicians and other licensed health care providers.
7. Bruker Corporation (NASDAQ:BRKR)
Number of Hedge Fund Holders: 34
On June 8, JPMorgan analyst Casey Woodring raised the price target on Bruker Corporation (NASDAQ:BRKR) to $65 from $45. The firm maintained an “Overweight rating” on the share. It updated the company model.
Days earlier, on June 4, Bruker Corporation reported its growing microbiology and infection diagnostics portfolio at ASM Microbe 2026. The firm detailed advances across microbial identification, sepsis diagnostics, molecular testing, and next-generation sequencing workflows.
The company said improvements to its MALDI Biotyper CA System include FDA-approved updates. It allows spotting of 549 clinically validated microbial species, along with software and workflow upgrades mapped out to improve speed and confidence in clinical labs.
Bruker also introduced new research-use tools. It includes libraries covering 5,325 species and more classifiers planned to strengthen outbreak investigation and surveillance.
The firm added that a rapid antimicrobial susceptibility testing workflow under development could make faster, actionable diagnostics to help earlier clinical decision-making in critically ill patients.
Bruker Corporation produces diagnostic tests and scientific instruments for customers in the biotechnology, pharmaceutical, applied markets, and life sciences areas.
6. Snap Inc. (NYSE:SNAP)
Number of Hedge Fund Holders: 46
Snap Inc. (NYSE:SNAP) is among the Best Brain-Computer Interface Stocks.
On June 16, Reuters reported that Snap Inc. launched its first consumer augmented-reality glasses. These are priced at $2,195, positioning the device as a new computing platform in the artificial intelligence era.
Launched at the Augmented World Expo in California, the report said the “Specs” glasses mark a major hardware push for the firm. The tech company has invested more than $3.5 billion in the specs unit during pressure on its advertising business and calls from an activist investor to spin off or shut it down.
Reuters said the glasses overlay digital content onto real-world views, offering features such as navigation, AI-powered responses, and video capture. Shipping is expected this fall in the US, UK, and France.
CEO Evan Spiegel told Reuters the company built “a totally new type of computer.” He also commented that rising memory chip costs have been “quite impactful” on pricing.
Shares fell 1.6%. Principal analyst at Moor Insights & Strategy, Anshel Sag, told Reuters the price “is still a bit on the high end.”
Snap Inc. is a technology company that works on a visual messaging application that was created to help people communicate through short videos and images.
5. Medtronic plc (NYSE:MDT)
Number of Hedge Fund Holders: 60
On June 8, Medtronic plc (NYSE:MDT) Chairman and CEO Geoffrey Martha said on Fox Business Network’s The Claman Countdown that the company now expects a $250 million tariff hit for fiscal 2027, down from a prior $300 million estimate due to supply chain adjustments. It includes $75 million in the first quarter.
Martha noted the figure could change given new US tariff threats targeting multiple trading partners emerge, saying, “we’ll have to re-evaluate that.”
He said tariffs remain “pretty meaningful,” surging year over year and adding pressure along with higher input costs such as fuel. He underlined that around 80% of Medtronic plc (NYSE:MDT)’s supply chain and over 90% of R&D are based in the US.
Martha pointed to growth as a buffer with a 78% revenue jump in cardiac ablation alongside strength in pacemakers, surgical, and spine businesses.
He also said the medtech firm put in $2 billion in acquisitions over the past fiscal year and invests $5 billion to $6 billion annually in innovation.
Medtronic plc (NYSE:MDT) is a medical technology company. It works in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through Cardiovascular Portfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit segments.
4. Abbott Laboratories (NYSE:ABT)
Number of Hedge Fund Holders: 73
Abbott Laboratories (NYSE:ABT) is among the Best Brain-Computer Interface Stocks.
On June 4, Reuters reported a federal judge ruled that Abbott Laboratories must face a proposed class-action lawsuit alleging it misled consumers by marketing PediaSure Grow & Gain drinks as “clinically proven” to help children grow.
US District Judge Paul Engelmayer said labeling featuring a giraffe and ruler-like marks could lead consumers to interpret “grow” as height gain, while “gain” implied weight. Hence, the claims will proceed, and Abbott Laboratories must defend.
In a 75-page decision, Engelmayer noted jurors could find the firm’s commercials reinforced that message, citing an ad showing a boy comparing himself to taller peers.
The corporation said its labeling is “appropriate” and backed by evidence, maintaining PediaSure supports children’s growth and development.
Plaintiff Joanne Noriega said her grandson remained short after a year of daily use but became overweight, while her lawyer James Denlea said he welcomed the ruling.
Abbott Laboratories discovers, develops, manufactures, and sells healthcare products. It operates through Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices segments.
3. Apple Inc. (NASDAQ:AAPL)
Number of Hedge Fund Holders: 170
On June 18, Reuters reported that Apple Inc. (NASDAQ:AAPL) will permit developers in Brazil to distribute iOS apps through alternative marketplaces and use payment options outside its in-app system under an agreement with antitrust regulator CADE.
The company said developers using the App Store in Brazil can include alternative payment methods. It can also direct users to external websites to complete transactions, growing distribution and payment flexibility.
The tech giant said the shift introduces “new options for developers.” However, the corporation cautioned that alternative distribution and payment channels may elevate risks, including fraud, malware, scams, and privacy threats.
Separately, Apple Inc. said it will apply safeguards such as app notarization, marketplace authorization, and protections for minors, given that Apps distributed outside the App Store will not receive the same level of review.
The firm pointed out that developers can adopt the changes immediately with iOS 26.5.
Apple Inc. designs, manufactures, and sells smartphones, personal computers, tablets, wearables, and accessories, as well as a variety of connected services. It functions in the Americas, Europe, Greater China, Japan, and the Rest of the Asia Pacific.
2. Meta Platforms, Inc. (NASDAQ:META)
Number of Hedge Fund Holders: 262
Meta Platforms, Inc. (NASDAQ:META) is among the Best Brain-Computer Interface Stocks.
On June 22, Reuters reported that Meta Platforms, Inc. will pause its internal Model Capability Initiative program, which tracks employee mouse movements, clicks, and keystrokes for artificial intelligence training. The firm is investigating data security concerns.
While citing documents it reviewed, Reuters reported sensitive employee data collected through the program was accessible to all Meta staffers, prompting an employee to file a high-priority security incident report. The internal documentation showed exposed data included “full prompts and transcriptions, private conversations, people & performance data, DSS sensitivity ratings (1-4).”
Meta Platforms, Inc. spokesperson Tracy Clayton told Reuters the company had “no indication at this time that any data was improperly accessed.” He also said the program was designed with privacy safeguards and is being paused during the investigation.
Reuters said the Model Capability Initiative was launched in April and was still recording as of Monday afternoon, as per an undisclosed source.
Meta Platforms, Inc. specializes in the creation of social media applications. It develops technology that allows individuals to connect and share, discover communities, and grow businesses.
1. NVIDIA Corporation (NASDAQ:NVDA)
Number of Hedge Fund Holders: 275
NVIDIA Corporation (NASDAQ:NVDA) is among the Best Brain-Computer Interface Stocks.
On June 22, CNBC reported that NVIDIA Corporation shares have underperformed in 2026. The firm rose about 12% compared with the VanEck Semiconductor ETF’s nearly 85% gain while slipping roughly 3% over the past month as investors are focusing on memory chips and infrastructure.
The report said growth in that segment has lifted companies such as Micron Technology and Sandisk, both up nearly 60% in the past month. Meanwhile, NVIDIA Corporation “sat on the sidelines” during the rotation.
CNBC, citing Ornn data, reported the artificial intelligence chipmaker’s B200 compute price peaked at $6.11 per hour on May 30 before falling to $4.22 by June 21.
CNBC stated that Kalshi traders now expect prices to remain below that peak through June, showing softer demand projections.
Finance professor at Santa Clara University, Seoyoung Kim, told CNBC that uncertainty over future GPU demand and supply leaves both buyers and manufacturers, including Nvidia, unsure how much capacity to plan for.
NVIDIA Corporation designs and manufactures computer graphics processors, chipsets, and related multimedia applications. It functions in two segments: graphics processing unit and compute and networking.
READ NEXT: 20 Best Performing Stocks in 2025 and 12 Best Food Stocks to Buy in 2026.
Hedge Fund Resource Center